Exelixis Clinical Site #1 is a clinical research site located in Indianapolis, Indiana, United States 46250.
Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.
Exelixis Clinical Site #1 has participated in 1 clinical trials.
Therapeutic areas: Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL), Mantle Cell Lymphoma (MCL).
Sponsors: Exelixis.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Indiana · View every site in Indianapolis
Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Exelixis Clinical Site #1 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Exelixis Clinical Site #1 has 1 clinical trials on record. Their work covers Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL), Mantle Cell Lymphoma (MCL).
Exelixis Clinical Site #1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.